Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2019
|
Juan Fernando Posada President - LA SMO |
SELL
Open market or private sale
|
Direct |
6,400
-11.64%
|
$678,400
$106.0 P/Share
|
|
May 03
2019
|
Loic Tassel President - Europe SMO |
SELL
Open market or private sale
|
Direct |
5,000
-37.72%
|
$530,000
$106.0 P/Share
|
|
May 03
2019
|
Loic Tassel President - Europe SMO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+27.39%
|
$315,000
$63.28 P/Share
|
|
May 03
2019
|
Juan Fernando Posada President - LA SMO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+14.81%
|
$315,000
$63.28 P/Share
|
|
May 02
2019
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,645
-80.32%
|
$1,012,725
$105.33 P/Share
|
|
May 02
2019
|
Juan Fernando Posada President - LA SMO |
SELL
Open market or private sale
|
Direct |
6,400
-11.07%
|
$672,000
$105.38 P/Share
|
|
May 02
2019
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
23,673
-9.48%
|
$2,485,665
$105.39 P/Share
|
|
May 02
2019
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
23,673
+8.66%
|
$1,586,091
$67.52 P/Share
|
|
May 02
2019
|
Juan Fernando Posada President - LA SMO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+14.22%
|
$315,000
$63.28 P/Share
|
|
May 01
2019
|
Price Matthew President - Greater China SMO |
SELL
Open market or private sale
|
Direct |
19,401
-42.41%
|
$2,056,506
$106.03 P/Share
|
|
May 01
2019
|
Price Matthew President - Greater China SMO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,401
+29.78%
|
$1,222,263
$63.05 P/Share
|
|
May 01
2019
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
3,980
-6.14%
|
$417,900
$105.85 P/Share
|
|
Apr 30
2019
|
Valarie L Sheppard Controller, Treas. & Group VP |
SELL
Open market or private sale
|
Direct |
26,891
-52.4%
|
$2,850,446
$106.32 P/Share
|
|
Apr 30
2019
|
Valarie L Sheppard Controller, Treas. & Group VP |
BUY
Exercise of conversion of derivative security
|
Direct |
26,891
+34.38%
|
$1,694,133
$63.28 P/Share
|
|
Apr 30
2019
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
837
-1.77%
|
$88,722
$106.0 P/Share
|
|
Apr 30
2019
|
Jeffrey K Schomburger Global Sales Officer, CBD |
SELL
Open market or private sale
|
Direct |
6,595
-30.76%
|
$699,070
$106.06 P/Share
|
|
Apr 30
2019
|
Juan Fernando Posada President - LA SMO |
SELL
Open market or private sale
|
Direct |
1,400
-5.27%
|
$148,400
$106.0 P/Share
|
|
Apr 26
2019
|
Juan Fernando Posada President - LA SMO |
SELL
Open market or private sale
|
Direct |
6,400
-10.09%
|
$672,000
$105.74 P/Share
|
|
Apr 26
2019
|
Juan Fernando Posada President - LA SMO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+13.17%
|
$315,000
$63.28 P/Share
|
|
Apr 26
2019
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Open market or private sale
|
Direct |
24,626
-52.43%
|
$2,561,104
$104.0 P/Share
|
|
Apr 26
2019
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,626
+34.4%
|
$1,551,438
$63.05 P/Share
|
|
Apr 26
2019
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
837
-1.74%
|
$87,885
$105.0 P/Share
|
|
Apr 26
2019
|
Ioannis Skoufalos Global Product Supply Officer |
SELL
Open market or private sale
|
Direct |
20,000
-54.89%
|
$2,100,000
$105.25 P/Share
|
|
Apr 26
2019
|
Ioannis Skoufalos Global Product Supply Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+35.44%
|
$1,520,000
$76.18 P/Share
|
|
Apr 26
2019
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
30,000
-11.71%
|
$3,150,000
$105.0 P/Share
|
|
Apr 26
2019
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+10.49%
|
$2,010,000
$67.52 P/Share
|
|
Apr 25
2019
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
6,161
-12.04%
|
$634,583
$103.1 P/Share
|
|
Apr 24
2019
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
1,065
-2.16%
|
$109,695
$103.47 P/Share
|
|
Apr 24
2019
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
609
-5.78%
|
$62,727
$103.47 P/Share
|
|
Mar 12
2019
|
Scott D Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
263
+0.33%
|
-
|
|
Mar 12
2019
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
275
+1.19%
|
-
|
|
Mar 12
2019
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
225
+1.57%
|
-
|
|
Mar 12
2019
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
300
+0.39%
|
-
|
|
Mar 12
2019
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
263
+0.67%
|
-
|
|
Mar 12
2019
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
225
+1.39%
|
-
|
|
Feb 28
2019
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
551
-4.97%
|
$53,998
$98.57 P/Share
|
|
Feb 28
2019
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
2,476
-4.79%
|
$242,648
$98.57 P/Share
|
|
Feb 28
2019
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
2,218
+16.67%
|
-
|
|
Feb 28
2019
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Direct |
11,734
+18.5%
|
-
|
|
Feb 28
2019
|
Deborah P Majoras Chief Legal Officer & Secy |
BUY
Grant, award, or other acquisition
|
Direct |
7,104
+12.19%
|
-
|
|
Feb 28
2019
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
2,311
-4.98%
|
$226,478
$98.57 P/Share
|
|
Feb 28
2019
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
459
-5.19%
|
$44,982
$98.57 P/Share
|
|
Feb 28
2019
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
2,765
-2.06%
|
$270,970
$98.57 P/Share
|
|
Feb 28
2019
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
740
+7.73%
|
-
|
|
Feb 28
2019
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,638
+5.39%
|
-
|
|
Feb 28
2019
|
Jeffrey K Schomburger Global Sales Officer, CBD |
SELL
Open market or private sale
|
Direct |
4,859
-18.47%
|
$476,182
$98.57 P/Share
|
|
Feb 28
2019
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Open market or private sale
|
Direct |
3,300
-4.19%
|
$323,400
$98.57 P/Share
|
|
Feb 28
2019
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
BUY
Grant, award, or other acquisition
|
Direct |
7,823
+9.04%
|
-
|
|
Feb 28
2019
|
Carolyn M Tastad CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
11,518
+15.09%
|
-
|
|
Feb 28
2019
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
1,493
-2.72%
|
$146,314
$98.57 P/Share
|